{"database": "openregs", "table": "documents", "is_view": false, "human_description_en": "where docket_id = \"FDA-2007-D-0369\" and posted_year = 2023 sorted by posted_date descending", "rows": [["FDA-2007-D-0369-0949", "FDA", "FDA-2007-D-0369", "PSG_214962 - Draft Guidance on Fingolimod Lauryl Sulfate", "Other", "Guidance", "2023-11-17T05:00:00Z", 2023, 11, "2023-11-17T05:00:00Z", "2024-01-17T04:59:59Z", "2024-11-12T06:22:46Z", null, 1, 0, "0900006486286f24"], ["FDA-2007-D-0369-0953", "FDA", "FDA-2007-D-0369", "PSG_214120 - Draft Guidance on Azacitidine", "Other", "Guidance", "2023-11-17T05:00:00Z", 2023, 11, "2023-11-17T05:00:00Z", "2024-01-17T04:59:59Z", "2024-11-12T06:22:47Z", null, 1, 0, "0900006486286f2d"], ["FDA-2007-D-0369-0955", "FDA", "FDA-2007-D-0369", "PSG_214958 - Draft Guidance on Deucravacitinib", "Other", "Guidance", "2023-11-17T05:00:00Z", 2023, 11, "2023-11-17T05:00:00Z", "2024-01-17T04:59:59Z", "2024-11-12T06:22:47Z", null, 1, 0, "0900006486286f31"], ["FDA-2007-D-0369-0967", "FDA", "FDA-2007-D-0369", "PSG_215446 - Draft Guidance on Edaravone", "Other", "Guidance", "2023-11-17T05:00:00Z", 2023, 11, "2023-11-17T05:00:00Z", "2024-01-17T04:59:59Z", "2024-11-12T06:22:49Z", null, 1, 0, "0900006486286f4a"], ["FDA-2007-D-0369-0933", "FDA", "FDA-2007-D-0369", "PSG_021254 - Draft Guidance on Fluticasone Propionate; Salmeterol Xinafoate", "Other", "Guidance", "2023-11-17T05:00:00Z", 2023, 11, "2023-11-17T05:00:00Z", "2024-01-17T04:59:59Z", "2024-11-12T06:22:44Z", null, 1, 0, "0900006486286f00"], ["FDA-2007-D-0369-0938", "FDA", "FDA-2007-D-0369", "PSG_021433 - Draft Guidance on Fluticasone Propionate", "Other", "Guidance", "2023-11-17T05:00:00Z", 2023, 11, "2023-11-17T05:00:00Z", "2024-01-17T04:59:59Z", "2024-11-12T06:22:44Z", null, 1, 0, "0900006486286f0a"], ["FDA-2007-D-0369-0937", "FDA", "FDA-2007-D-0369", "PSG_014602 - Draft Guidance on Betamethasone Acetate; Betamethasone Sodium Phosphate", "Other", "Guidance", "2023-11-17T05:00:00Z", 2023, 11, "2023-11-17T05:00:00Z", "2024-01-17T04:59:59Z", "2024-11-12T06:22:44Z", null, 1, 0, "0900006486286f08"], ["FDA-2007-D-0369-0945", "FDA", "FDA-2007-D-0369", "PSG_205641 - Draft Guidance on Mometasone Furoate", "Other", "Guidance", "2023-11-17T05:00:00Z", 2023, 11, "2023-11-17T05:00:00Z", "2024-01-17T04:59:59Z", "2024-11-12T06:22:46Z", null, 1, 0, "0900006486286f18"], ["FDA-2007-D-0369-0930", "FDA", "FDA-2007-D-0369", "PSG_017643 - Draft Guidance on Soybean Oil", "Other", "Guidance", "2023-11-17T05:00:00Z", 2023, 11, "2023-11-17T05:00:00Z", "2024-01-17T04:59:59Z", "2024-11-12T06:22:43Z", null, 1, 0, "0900006486287259"], ["FDA-2007-D-0369-0942", "FDA", "FDA-2007-D-0369", "PSG_206317 - Draft Guidance on Ferric Pyrophosphate Citrate", "Other", "Guidance", "2023-11-17T05:00:00Z", 2023, 11, "2023-11-17T05:00:00Z", "2024-01-17T04:59:59Z", "2024-11-12T06:22:45Z", null, 1, 0, "0900006486286f12"], ["FDA-2007-D-0369-0960", "FDA", "FDA-2007-D-0369", "PSG_215256 - Draft Guidance on Semaglutide", "Other", "Guidance", "2023-11-17T05:00:00Z", 2023, 11, "2023-11-17T05:00:00Z", "2024-01-17T04:59:59Z", "2024-11-12T06:22:48Z", null, 1, 0, "0900006486286f3c"], ["FDA-2007-D-0369-0948", "FDA", "FDA-2007-D-0369", "PSG_209637 - Draft Guidance on Semaglutide", "Other", "Guidance", "2023-11-17T05:00:00Z", 2023, 11, "2023-11-17T05:00:00Z", "2024-01-17T04:59:59Z", "2024-12-14T02:00:54Z", null, 1, 0, "0900006486286f22"], ["FDA-2007-D-0369-0959", "FDA", "FDA-2007-D-0369", "PSG_215092 - Draft Guidance on Omidenepag Isopropyl", "Other", "Guidance", "2023-11-17T05:00:00Z", 2023, 11, "2023-11-17T05:00:00Z", "2024-01-17T04:59:59Z", "2024-11-12T06:22:48Z", null, 1, 0, "0900006486286f3a"], ["FDA-2007-D-0369-0962", "FDA", "FDA-2007-D-0369", "PSG_216903 - Draft Guidance on Glycopyrrolate; Neostigmine Methylsulfate", "Other", "Guidance", "2023-11-17T05:00:00Z", 2023, 11, "2023-11-17T05:00:00Z", "2024-01-17T04:59:59Z", "2024-11-12T06:22:49Z", null, 1, 0, "0900006486286f40"], ["FDA-2007-D-0369-0928", "FDA", "FDA-2007-D-0369", "PSG_021395 - Draft Guidance on Tiotropium Bromide", "Other", "Guidance", "2023-11-17T05:00:00Z", 2023, 11, "2023-11-17T05:00:00Z", "2024-01-17T04:59:59Z", "2024-11-12T06:22:43Z", null, 1, 0, "0900006486287255"], ["FDA-2007-D-0369-0929", "FDA", "FDA-2007-D-0369", "PSG_020503 - Draft Guidance on Albuterol Sulfate", "Other", "Guidance", "2023-11-17T05:00:00Z", 2023, 11, "2023-11-17T05:00:00Z", "2024-01-17T04:59:59Z", "2024-11-12T06:22:43Z", null, 1, 0, "0900006486287257"], ["FDA-2007-D-0369-0944", "FDA", "FDA-2007-D-0369", "PSG_022544 - Draft Guidance on Gabapentin", "Other", "Guidance", "2023-11-17T05:00:00Z", 2023, 11, "2023-11-17T05:00:00Z", "2024-01-17T04:59:59Z", "2024-11-12T06:22:45Z", null, 1, 0, "0900006486286f16"], ["FDA-2007-D-0369-0954", "FDA", "FDA-2007-D-0369", "PSG_209988 - Draft Guidance on Furosemide", "Other", "Guidance", "2023-11-17T05:00:00Z", 2023, 11, "2023-11-17T05:00:00Z", "2024-01-17T04:59:59Z", "2024-11-12T06:22:47Z", null, 1, 0, "0900006486286f2f"], ["FDA-2007-D-0369-0935", "FDA", "FDA-2007-D-0369", "PSG_017768 - Draft Guidance on Chlorhexidine Gluconate", "Other", "Guidance", "2023-11-17T05:00:00Z", 2023, 11, "2023-11-17T05:00:00Z", "2024-01-17T04:59:59Z", "2024-11-12T06:22:44Z", null, 1, 0, "0900006486286f04"], ["FDA-2007-D-0369-0964", "FDA", "FDA-2007-D-0369", "PSG_215401 - Draft Guidance on Dextroamphetamine", "Other", "Guidance", "2023-11-17T05:00:00Z", 2023, 11, "2023-11-17T05:00:00Z", "2024-01-17T04:59:59Z", "2024-11-12T06:22:49Z", null, 1, 0, "0900006486286f44"], ["FDA-2007-D-0369-0966", "FDA", "FDA-2007-D-0369", "PSG_216354 - Draft Guidance on Deutetrabenazine", "Other", "Guidance", "2023-11-17T05:00:00Z", 2023, 11, "2023-11-17T05:00:00Z", "2024-01-17T04:59:59Z", "2024-11-12T06:22:49Z", null, 1, 0, "0900006486286f48"], ["FDA-2007-D-0369-0958", "FDA", "FDA-2007-D-0369", "PSG_215272 - Draft Guidance on Tapinarof", "Other", "Guidance", "2023-11-17T05:00:00Z", 2023, 11, "2023-11-17T05:00:00Z", "2024-01-17T04:59:59Z", "2024-11-12T06:22:48Z", null, 1, 0, "0900006486286f38"], ["FDA-2007-D-0369-0927", "FDA", "FDA-2007-D-0369", "Product-Specific Guidances; Draft and Revised Draft Guidances for Industry;\nAvailability", "Notice", "Notice of Availability", "2023-11-17T05:00:00Z", 2023, 11, "2023-11-17T05:00:00Z", "2024-01-17T04:59:59Z", "2024-05-16T20:18:05Z", "2023-25485", 0, 0, "090000648628cbd3"], ["FDA-2007-D-0369-0934", "FDA", "FDA-2007-D-0369", "PSG_021344 - Draft Guidance on Fulvestrant", "Other", "Guidance", "2023-11-17T05:00:00Z", 2023, 11, "2023-11-17T05:00:00Z", "2024-01-17T04:59:59Z", "2023-11-17T20:16:37Z", null, 0, 0, "0900006486286f02"], ["FDA-2007-D-0369-0939", "FDA", "FDA-2007-D-0369", "PSG_208551 - Draft Guidance on Ferric Pyrophosphate Citrate", "Other", "Guidance", "2023-11-17T05:00:00Z", 2023, 11, "2023-11-17T05:00:00Z", "2024-01-17T04:59:59Z", "2024-11-12T06:22:45Z", null, 1, 0, "0900006486286f0c"], ["FDA-2007-D-0369-0947", "FDA", "FDA-2007-D-0369", "PSG_022180 - Draft Guidance on Ferumoxytol", "Other", "Guidance", "2023-11-17T05:00:00Z", 2023, 11, "2023-11-17T05:00:00Z", "2024-01-17T04:59:59Z", "2024-11-12T06:22:46Z", null, 1, 0, "0900006486286f20"], ["FDA-2007-D-0369-0957", "FDA", "FDA-2007-D-0369", "PSG_214665 - Draft Guidance on Sotorasib", "Other", "Guidance", "2023-11-17T05:00:00Z", 2023, 11, "2023-11-17T05:00:00Z", "2024-01-17T04:59:59Z", "2024-11-12T06:22:48Z", null, 1, 0, "0900006486286f36"], ["FDA-2007-D-0369-0931", "FDA", "FDA-2007-D-0369", "PSG_009170 - Draft Guidance on Primidone", "Other", "Guidance", "2023-11-17T05:00:00Z", 2023, 11, "2023-11-17T05:00:00Z", "2024-01-17T04:59:59Z", "2024-11-12T06:22:43Z", null, 1, 0, "0900006486286efc"], ["FDA-2007-D-0369-0946", "FDA", "FDA-2007-D-0369", "PSG_021897 - Draft Guidance on Naltrexone", "Other", "Guidance", "2023-11-17T05:00:00Z", 2023, 11, "2023-11-17T05:00:00Z", "2024-01-17T04:59:59Z", "2024-11-12T06:22:46Z", null, 1, 0, "0900006486286f1e"], ["FDA-2007-D-0369-0950", "FDA", "FDA-2007-D-0369", "PSG_209354 - Draft Guidance on Halobetasol Propionate; Tazarotene", "Other", "Guidance", "2023-11-17T05:00:00Z", 2023, 11, "2023-11-17T05:00:00Z", "2024-01-17T04:59:59Z", "2024-11-12T06:22:46Z", null, 1, 0, "0900006486286f26"], ["FDA-2007-D-0369-0956", "FDA", "FDA-2007-D-0369", "PSG_212860 - Draft Guidance on Ferric Pyrophosphate Citrate", "Other", "Guidance", "2023-11-17T05:00:00Z", 2023, 11, "2023-11-17T05:00:00Z", "2024-01-17T04:59:59Z", "2024-11-12T06:22:47Z", null, 1, 0, "0900006486286f34"], ["FDA-2007-D-0369-0963", "FDA", "FDA-2007-D-0369", "PSG_215904 - Draft Guidance on Ganaxolone", "Other", "Guidance", "2023-11-17T05:00:00Z", 2023, 11, "2023-11-17T05:00:00Z", "2024-01-17T04:59:59Z", "2024-11-12T06:22:49Z", null, 1, 0, "0900006486286f42"], ["FDA-2007-D-0369-0932", "FDA", "FDA-2007-D-0369", "PSG_020622 - Draft Guidance on Glatiramer Acetate", "Other", "Guidance", "2023-11-17T05:00:00Z", 2023, 11, "2023-11-17T05:00:00Z", "2024-01-17T04:59:59Z", "2024-11-12T06:22:43Z", null, 1, 0, "0900006486286efe"], ["FDA-2007-D-0369-0941", "FDA", "FDA-2007-D-0369", "PSG_208215 - Draft Guidance on Emtricitabine; Tenofovir Alafenamide Fumarate", "Other", "Guidance", "2023-11-17T05:00:00Z", 2023, 11, "2023-11-17T05:00:00Z", "2024-01-17T04:59:59Z", "2024-11-12T06:22:45Z", null, 1, 0, "0900006486286f10"], ["FDA-2007-D-0369-0943", "FDA", "FDA-2007-D-0369", "PSG_021730 - Draft Guidance on Levalbuterol Tartrate", "Other", "Guidance", "2023-11-17T05:00:00Z", 2023, 11, "2023-11-17T05:00:00Z", "2024-01-17T04:59:59Z", "2024-11-12T06:22:45Z", null, 1, 0, "0900006486286f14"], ["FDA-2007-D-0369-0951", "FDA", "FDA-2007-D-0369", "PSG_210655 - Draft Guidance on Risperidone", "Other", "Guidance", "2023-11-17T05:00:00Z", 2023, 11, "2023-11-17T05:00:00Z", "2024-01-17T04:59:59Z", "2024-11-12T06:22:47Z", null, 1, 0, "0900006486286f29"], ["FDA-2007-D-0369-0936", "FDA", "FDA-2007-D-0369", "PSG_017920 - Draft Guidance on Cimetidine", "Other", "Guidance", "2023-11-17T05:00:00Z", 2023, 11, "2023-11-17T05:00:00Z", "2024-01-17T04:59:59Z", "2024-11-12T06:22:44Z", null, 1, 0, "0900006486286f06"], ["FDA-2007-D-0369-0940", "FDA", "FDA-2007-D-0369", "PSG_021929 - Draft Guidance on Budesonide; Formoterol Fumarate Dihydrate", "Other", "Guidance", "2023-11-17T05:00:00Z", 2023, 11, "2023-11-17T05:00:00Z", "2024-01-17T04:59:59Z", "2024-11-12T06:22:45Z", null, 1, 0, "0900006486286f0e"], ["FDA-2007-D-0369-0952", "FDA", "FDA-2007-D-0369", "PSG_214801 - Draft Guidance on Futibatinib", "Other", "Guidance", "2023-11-17T05:00:00Z", 2023, 11, "2023-11-17T05:00:00Z", "2024-01-17T04:59:59Z", "2024-11-12T06:22:47Z", null, 1, 0, "0900006486286f2b"], ["FDA-2007-D-0369-0961", "FDA", "FDA-2007-D-0369", "PSG_216472 - Draft Guidance on Latanoprost", "Other", "Guidance", "2023-11-17T05:00:00Z", 2023, 11, "2023-11-17T05:00:00Z", "2024-01-17T04:59:59Z", "2024-11-12T06:22:48Z", null, 1, 0, "0900006486286f3e"], ["FDA-2007-D-0369-0965", "FDA", "FDA-2007-D-0369", "PSG_215428 - Draft Guidance on Citalopram Hydrobromide", "Other", "Guidance", "2023-11-17T05:00:00Z", 2023, 11, "2023-11-17T05:00:00Z", "2024-01-17T04:59:59Z", "2024-11-12T06:22:49Z", null, 1, 0, "0900006486286f46"], ["FDA-2007-D-0369-0887", "FDA", "FDA-2007-D-0369", "PSG_021258 Draft Guidance on Estradiol; Levonorgestrel", "Other", "Guidance", "2023-08-22T04:00:00Z", 2023, 8, "2023-08-22T04:00:00Z", "2023-10-24T03:59:59Z", "2024-11-11T21:31:05Z", null, 1, 0, "0900006485ed5b4e"], ["FDA-2007-D-0369-0891", "FDA", "FDA-2007-D-0369", "PSG_201739 Draft Guidance on Epinephrine", "Other", "Guidance", "2023-08-22T04:00:00Z", 2023, 8, "2023-08-22T04:00:00Z", "2023-08-23T03:59:59Z", "2024-11-11T21:31:06Z", null, 1, 0, "0900006485ed5b5c"], ["FDA-2007-D-0369-0921", "FDA", "FDA-2007-D-0369", "PSG_216359 Draft Guidance on Midazolam Hydrochloride", "Other", "Guidance", "2023-08-22T04:00:00Z", 2023, 8, "2023-08-22T04:00:00Z", "2023-10-24T03:59:59Z", "2024-11-11T21:31:08Z", null, 1, 0, "0900006485ed6325"], ["FDA-2007-D-0369-0902", "FDA", "FDA-2007-D-0369", "PSG_020746 Draft Guidance on Budesonide", "Other", "Guidance", "2023-08-22T04:00:00Z", 2023, 8, "2023-08-22T04:00:00Z", "2023-10-24T03:59:59Z", "2024-11-11T21:31:05Z", null, 1, 0, "0900006485ed5b46"], ["FDA-2007-D-0369-0888", "FDA", "FDA-2007-D-0369", "PSG_021527 Draft Guidance on Ipratropium Bromide", "Other", "Guidance", "2023-08-22T04:00:00Z", 2023, 8, "2023-08-22T04:00:00Z", "2023-10-24T03:59:59Z", "2024-11-11T21:31:06Z", null, 1, 0, "0900006485ed5b50"], ["FDA-2007-D-0369-0916", "FDA", "FDA-2007-D-0369", "PSG_216227 Draft Guidance on Chloroprocaine Hydrochloride", "Other", "Guidance", "2023-08-22T04:00:00Z", 2023, 8, "2023-08-22T04:00:00Z", null, "2024-11-11T21:31:07Z", null, 1, 0, "0900006485ed6319"], ["FDA-2007-D-0369-0900", "FDA", "FDA-2007-D-0369", "PSG_008816 Draft Guidance on Lidocaine Hydrochloride", "Other", "Guidance", "2023-08-22T04:00:00Z", 2023, 8, "2023-08-22T04:00:00Z", "2023-10-24T03:59:59Z", "2024-11-11T21:31:04Z", null, 1, 0, "0900006485ed5b42"], ["FDA-2007-D-0369-0915", "FDA", "FDA-2007-D-0369", "PSG_215833 Draft Guidance on Lutetium Lu-177 Vipivotide Tetraxetan", "Other", "Guidance", "2023-08-22T04:00:00Z", 2023, 8, "2023-08-22T04:00:00Z", "2023-10-24T03:59:59Z", "2024-11-11T21:31:07Z", null, 1, 0, "0900006485ed627c"], ["FDA-2007-D-0369-0901", "FDA", "FDA-2007-D-0369", "PSG_020468 Draft Guidance on Triamcinolone Acetonide", "Other", "Guidance", "2023-08-22T04:00:00Z", 2023, 8, "2023-08-22T04:00:00Z", "2023-10-24T03:59:59Z", "2024-11-11T21:31:05Z", null, 1, 0, "0900006485ed5b44"], ["FDA-2007-D-0369-0896", "FDA", "FDA-2007-D-0369", "PSG_213433 Draft Guidance on Clascoterone", "Other", "Guidance", "2023-08-22T04:00:00Z", 2023, 8, "2023-08-22T04:00:00Z", "2023-10-24T03:59:59Z", "2024-11-07T01:23:13Z", null, 1, 0, "0900006485ed5c47"], ["FDA-2007-D-0369-0905", "FDA", "FDA-2007-D-0369", "PSG_214487 Draft Guidance on Avacopan", "Other", "Guidance", "2023-08-22T04:00:00Z", 2023, 8, "2023-08-22T04:00:00Z", "2023-10-24T03:59:59Z", "2024-11-07T01:23:37Z", null, 1, 0, "0900006485ed5c59"], ["FDA-2007-D-0369-0914", "FDA", "FDA-2007-D-0369", "PSG_214662 Draft Guidance on Maralixibat Chloride", "Other", "Guidance", "2023-08-22T04:00:00Z", 2023, 8, "2023-08-22T04:00:00Z", "2023-10-24T03:59:59Z", "2024-11-07T01:23:40Z", null, 1, 0, "0900006485ed5c77"], ["FDA-2007-D-0369-0920", "FDA", "FDA-2007-D-0369", "PSG_215866 Draft Guidance on Tirzepatide", "Other", "Guidance", "2023-08-22T04:00:00Z", 2023, 8, "2023-08-22T04:00:00Z", "2023-10-24T03:59:59Z", "2025-02-23T05:15:13Z", null, 1, 0, "0900006485ed6321"], ["FDA-2007-D-0369-0907", "FDA", "FDA-2007-D-0369", "PSG_214103 Draft Guidance on Lumasiran Sodium", "Other", "Guidance", "2023-08-22T04:00:00Z", 2023, 8, "2023-08-22T04:00:00Z", "2023-10-24T03:59:59Z", "2024-11-07T01:23:38Z", null, 1, 0, "0900006485ed5c5d"], ["FDA-2007-D-0369-0911", "FDA", "FDA-2007-D-0369", "PSG_214998 Draft Guidance on Mavacamten", "Other", "Guidance", "2023-08-22T04:00:00Z", 2023, 8, "2023-08-22T04:00:00Z", "2023-10-24T03:59:59Z", "2024-11-07T01:23:38Z", null, 1, 0, "0900006485ed5c71"], ["FDA-2007-D-0369-0904", "FDA", "FDA-2007-D-0369", "PSG_214028 Draft Guidance on Pilocarpine Hydrochloride", "Other", "Guidance", "2023-08-22T04:00:00Z", 2023, 8, "2023-08-22T04:00:00Z", "2023-10-24T03:59:59Z", "2024-11-07T01:23:37Z", null, 1, 0, "0900006485ed5c4d"], ["FDA-2007-D-0369-0890", "FDA", "FDA-2007-D-0369", "PSG_022004 Draft Guidance on Ciclesonide", "Other", "Guidance", "2023-08-22T04:00:00Z", 2023, 8, "2023-08-22T04:00:00Z", "2023-10-24T03:59:59Z", "2024-11-11T21:31:06Z", null, 1, 0, "0900006485ed5b5a"], ["FDA-2007-D-0369-0892", "FDA", "FDA-2007-D-0369", "PSG_205920 Draft Guidance on Epinephrine", "Other", "Guidance", "2023-08-22T04:00:00Z", 2023, 8, "2023-08-22T04:00:00Z", "2023-10-24T03:59:59Z", "2024-11-11T21:31:06Z", null, 1, 0, "0900006485ed5b5e"], ["FDA-2007-D-0369-0917", "FDA", "FDA-2007-D-0369", "PSG_215888 Draft Guidance on Oteseconazole", "Other", "Guidance", "2023-08-22T04:00:00Z", 2023, 8, "2023-08-22T04:00:00Z", "2023-10-24T03:59:59Z", "2024-11-11T21:31:07Z", null, 1, 0, "0900006485ed631b"], ["FDA-2007-D-0369-0919", "FDA", "FDA-2007-D-0369", "PSG_216196 Draft Guidance on Mitapivat Sulfate", "Other", "Guidance", "2023-08-22T04:00:00Z", 2023, 8, "2023-08-22T04:00:00Z", null, "2024-11-11T21:31:08Z", null, 1, 0, "0900006485ed631f"], ["FDA-2007-D-0369-0885", "FDA", "FDA-2007-D-0369", "PSG_020911 Draft Guidance on Beclomethasone Dipropionate", "Other", "Guidance", "2023-08-22T04:00:00Z", 2023, 8, "2023-08-22T04:00:00Z", "2023-10-24T03:59:59Z", "2024-11-11T21:31:05Z", null, 1, 0, "0900006485ed5b4a"], ["FDA-2007-D-0369-0903", "FDA", "FDA-2007-D-0369", "PSG_021234 Draft Guidance on Diclofenac Epolamine", "Other", "Guidance", "2023-08-22T04:00:00Z", 2023, 8, "2023-08-22T04:00:00Z", "2023-10-24T03:59:59Z", "2024-11-11T21:31:05Z", null, 1, 0, "0900006485ed5b48"], ["FDA-2007-D-0369-0893", "FDA", "FDA-2007-D-0369", "PSG_208712 Draft Guidance on Pacritinib Citrate", "Other", "Guidance", "2023-08-22T04:00:00Z", 2023, 8, "2023-08-22T04:00:00Z", "2023-10-24T03:59:59Z", "2024-11-07T01:23:12Z", null, 1, 0, "0900006485ed5c34"], ["FDA-2007-D-0369-0897", "FDA", "FDA-2007-D-0369", "PSG_213137 Draft Guidance on Voxelotor", "Other", "Guidance", "2023-08-22T04:00:00Z", 2023, 8, "2023-08-22T04:00:00Z", "2023-10-24T03:59:59Z", "2024-11-07T01:23:13Z", null, 1, 0, "0900006485ed5c49"], ["FDA-2007-D-0369-0906", "FDA", "FDA-2007-D-0369", "PSG_213581 Draft Guidance on Atropine Sulfate", "Other", "Guidance", "2023-08-22T04:00:00Z", 2023, 8, "2023-08-22T04:00:00Z", "2023-08-23T03:59:59Z", "2024-11-07T01:23:37Z", null, 1, 0, "0900006485ed5c5b"], ["FDA-2007-D-0369-0884", "FDA", "FDA-2007-D-0369", "Product-Specific Guidances; Draft and Revised Draft Guidances for Industry;\nAvailability", "Notice", "Notice of Availability", "2023-08-22T04:00:00Z", 2023, 8, "2023-08-22T04:00:00Z", null, "2023-08-22T13:37:43Z", "2023-18026", 0, 0, "0900006485ed5264"], ["FDA-2007-D-0369-0886", "FDA", "FDA-2007-D-0369", "PSG_021658 Draft Guidance on Ciclesonide", "Other", "Guidance", "2023-08-22T04:00:00Z", 2023, 8, "2023-08-22T04:00:00Z", "2023-10-24T03:59:59Z", "2024-11-11T21:31:05Z", null, 1, 0, "0900006485ed5b4c"], ["FDA-2007-D-0369-0918", "FDA", "FDA-2007-D-0369", "PSG_215358 Draft Guidance on Asciminib Hydrochloride", "Other", "Guidance", "2023-08-22T04:00:00Z", 2023, 8, "2023-08-22T04:00:00Z", "2023-10-24T03:59:59Z", "2024-11-11T21:31:08Z", null, 1, 0, "0900006485ed631d"], ["FDA-2007-D-0369-0898", "FDA", "FDA-2007-D-0369", "PSG_212097 Draft Guidance on Glucagon", "Other", "Guidance", "2023-08-22T04:00:00Z", 2023, 8, "2023-08-22T04:00:00Z", "2023-10-24T03:59:59Z", "2024-11-07T01:23:40Z", null, 1, 0, "0900006485ed5c4b"], ["FDA-2007-D-0369-0909", "FDA", "FDA-2007-D-0369", "PSG_214985 Draft Guidance on Daridorexant Hydrochloride", "Other", "Guidance", "2023-08-22T04:00:00Z", 2023, 8, "2023-08-22T04:00:00Z", "2023-10-24T03:59:59Z", "2024-11-07T01:23:38Z", null, 1, 0, "0900006485ed5c61"], ["FDA-2007-D-0369-0895", "FDA", "FDA-2007-D-0369", "PSG_211746 Draft Guidance on Mometasone Furoate; Olopatadine Hydrochloride", "Other", "Guidance", "2023-08-22T04:00:00Z", 2023, 8, "2023-08-22T04:00:00Z", "2023-10-24T03:59:59Z", "2024-11-07T01:23:13Z", null, 1, 0, "0900006485ed5c45"], ["FDA-2007-D-0369-0908", "FDA", "FDA-2007-D-0369", "PSG_213871 Draft Guidance on Abrocitinib", "Other", "Guidance", "2023-08-22T04:00:00Z", 2023, 8, "2023-08-22T04:00:00Z", "2023-10-24T03:59:59Z", "2024-11-07T01:23:38Z", null, 1, 0, "0900006485ed5c5f"], ["FDA-2007-D-0369-0912", "FDA", "FDA-2007-D-0369", "PSG_215310 Draft Guidance on Mobocertinib Succinate", "Other", "Guidance", "2023-08-22T04:00:00Z", 2023, 8, "2023-08-22T04:00:00Z", "2023-08-23T03:59:59Z", "2024-11-07T01:23:38Z", null, 1, 0, "0900006485ed5c73"], ["FDA-2007-D-0369-0899", "FDA", "FDA-2007-D-0369", "PSG_019389 Draft Guidance on Beclomethasone Dipropionate Monohydrate", "Other", "Guidance", "2023-08-22T04:00:00Z", 2023, 8, "2023-08-22T04:00:00Z", "2023-10-24T03:59:59Z", "2024-11-11T21:31:04Z", null, 1, 0, "0900006485ed5b27"], ["FDA-2007-D-0369-0889", "FDA", "FDA-2007-D-0369", "PSG_022033 Draft Guidance on Fluvoxamine Maleate", "Other", "Guidance", "2023-08-22T04:00:00Z", 2023, 8, "2023-08-22T04:00:00Z", "2023-10-24T03:59:59Z", "2024-11-11T21:31:06Z", null, 1, 0, "0900006485ed5b58"], ["FDA-2007-D-0369-0922", "FDA", "FDA-2007-D-0369", "PSG_215515 Draft Guidance on Vutrisiran Sodium", "Other", "Guidance", "2023-08-22T04:00:00Z", 2023, 8, "2023-08-22T04:00:00Z", "2023-10-24T03:59:59Z", "2024-11-11T21:31:08Z", null, 1, 0, "0900006485ed6327"], ["FDA-2007-D-0369-0910", "FDA", "FDA-2007-D-0369", "PSG_215206 Draft Guidance on Atogepant", "Other", "Guidance", "2023-08-22T04:00:00Z", 2023, 8, "2023-08-22T04:00:00Z", "2023-10-24T03:59:59Z", "2024-11-07T01:23:38Z", null, 1, 0, "0900006485ed5c6f"], ["FDA-2007-D-0369-0894", "FDA", "FDA-2007-D-0369", "PSG_207921 Draft Guidance on Beclomethasone Dipropionate", "Other", "Guidance", "2023-08-22T04:00:00Z", 2023, 8, "2023-08-22T04:00:00Z", "2023-10-24T03:59:59Z", "2024-11-07T01:23:12Z", null, 1, 0, "0900006485ed5c36"], ["FDA-2007-D-0369-0913", "FDA", "FDA-2007-D-0369", "PSG_215309 Draft Guidance on Ruxolitinib Phosphate", "Other", "Guidance", "2023-08-22T04:00:00Z", 2023, 8, "2023-08-22T04:00:00Z", "2023-10-24T03:59:59Z", "2024-11-07T01:23:40Z", null, 1, 0, "0900006485ed5c75"], ["FDA-2007-D-0369-0867", "FDA", "FDA-2007-D-0369", "PSG_214793 - Draft Guidance on Piflufolastat F-18", "Other", "Guidance", "2023-05-19T04:00:00Z", 2023, 5, "2023-05-19T04:00:00Z", "2023-07-19T03:59:59Z", "2024-11-07T01:34:12Z", null, 1, 0, "0900006485a20d0a"], ["FDA-2007-D-0369-0868", "FDA", "FDA-2007-D-0369", "PSG_214916 - Draft Guidance on Difelikefalin Acetate", "Other", "Guidance", "2023-05-19T04:00:00Z", 2023, 5, "2023-05-19T04:00:00Z", "2023-07-18T03:59:59Z", "2024-11-07T01:34:15Z", null, 1, 0, "0900006485a20c85"], ["FDA-2007-D-0369-0860", "FDA", "FDA-2007-D-0369", "PSG_213691- Draft Guidance on Clobetasol Propionate", "Other", "Guidance", "2023-05-19T04:00:00Z", 2023, 5, "2023-05-19T04:00:00Z", "2023-07-19T03:59:59Z", "2024-11-07T01:34:19Z", null, 1, 0, "0900006485a204e2"], ["FDA-2007-D-0369-0866", "FDA", "FDA-2007-D-0369", "PSG_214783 - Draft Guidance on Belumosudil Mesylate", "Other", "Guidance", "2023-05-19T04:00:00Z", 2023, 5, "2023-05-19T04:00:00Z", "2023-07-19T03:59:59Z", "2024-11-07T01:34:14Z", null, 1, 0, "0900006485a20c81"], ["FDA-2007-D-0369-0871", "FDA", "FDA-2007-D-0369", "PSG_215457 - Draft Guidance on Naloxone Hydrochloride", "Other", "Guidance", "2023-05-19T04:00:00Z", 2023, 5, "2023-05-19T04:00:00Z", "2023-07-19T03:59:59Z", "2024-11-07T01:34:13Z", null, 1, 0, "0900006485a20c89"], ["FDA-2007-D-0369-0874", "FDA", "FDA-2007-D-0369", "PSG_018152 - Draft Guidance on Lithium Carbonate", "Other", "Guidance", "2023-05-19T04:00:00Z", 2023, 5, "2023-05-19T04:00:00Z", "2023-07-19T03:59:59Z", "2024-11-07T01:34:18Z", null, 1, 0, "0900006485a23167"], ["FDA-2007-D-0369-0857", "FDA", "FDA-2007-D-0369", "Product-Specific Guidances; Draft and Revised Draft Guidances for Industry; Availability", "Notice", "Notice of Availability", "2023-05-19T04:00:00Z", 2023, 5, "2023-05-19T04:00:00Z", null, "2023-05-19T15:39:54Z", "2023-10710", 0, 0, "0900006485a22a81"], ["FDA-2007-D-0369-0865", "FDA", "FDA-2007-D-0369", "PSG_214461 - Draft Guidance on Brincidofovir", "Other", "Guidance", "2023-05-19T04:00:00Z", 2023, 5, "2023-05-19T04:00:00Z", "2023-07-19T03:59:59Z", "2024-11-07T01:34:14Z", null, 1, 0, "0900006485a2057a"], ["FDA-2007-D-0369-0863", "FDA", "FDA-2007-D-0369", "PSG_214410 - Draft Guidance on Baloxavir Marboxil", "Other", "Guidance", "2023-05-19T04:00:00Z", 2023, 5, "2023-05-19T04:00:00Z", "2023-07-19T03:59:59Z", "2024-11-07T01:34:11Z", null, 1, 0, "0900006485a20577"], ["FDA-2007-D-0369-0875", "FDA", "FDA-2007-D-0369", "PSG_018558 - Draft Guidance on Lithium Carbonate", "Other", "Guidance", "2023-05-19T04:00:00Z", 2023, 5, "2023-05-19T04:00:00Z", "2023-07-19T03:59:59Z", "2024-11-07T01:34:18Z", null, 1, 0, "0900006485a23169"], ["FDA-2007-D-0369-0858", "FDA", "FDA-2007-D-0369", "PSG_213312 Draft Guidance on Sirolimus", "Other", "Guidance", "2023-05-19T04:00:00Z", 2023, 5, "2023-05-19T04:00:00Z", "2023-07-19T03:59:59Z", "2024-11-07T01:34:10Z", null, 1, 0, "0900006485a1e362"], ["FDA-2007-D-0369-0861", "FDA", "FDA-2007-D-0369", "PSG_213026 - Draft Guidance on Casimersen", "Other", "Guidance", "2023-05-19T04:00:00Z", 2023, 5, "2023-05-19T04:00:00Z", "2023-07-19T03:59:59Z", "2024-11-07T01:34:14Z", null, 1, 0, "0900006485a20573"], ["FDA-2007-D-0369-0862", "FDA", "FDA-2007-D-0369", "PSG_214012- Draft Guidance on Inclisiran Sodium", "Other", "Guidance", "2023-05-19T04:00:00Z", 2023, 5, "2023-05-19T04:00:00Z", "2023-07-19T03:59:59Z", "2024-11-07T01:34:14Z", null, 1, 0, "0900006485a20575"], ["FDA-2007-D-0369-0876", "FDA", "FDA-2007-D-0369", "PSG_207925 - Draft Guidance on Ivacaftor", "Other", "Guidance", "2023-05-19T04:00:00Z", 2023, 5, "2023-05-19T04:00:00Z", "2023-07-19T03:59:59Z", "2024-11-07T01:34:14Z", null, 1, 0, "0900006485a2283a"], ["FDA-2007-D-0369-0872", "FDA", "FDA-2007-D-0369", "PSG_211911- Draft Guidance on Bimatoprost", "Other", "Guidance", "2023-05-19T04:00:00Z", 2023, 5, "2023-05-19T04:00:00Z", "2023-07-19T03:59:59Z", "2024-11-07T01:34:22Z", null, 1, 0, "0900006485a22d9c"], ["FDA-2007-D-0369-0869", "FDA", "FDA-2007-D-0369", "PSG_215341- Draft Guidance on Finerenone", "Other", "Guidance", "2023-05-19T04:00:00Z", 2023, 5, "2023-05-19T04:00:00Z", "2023-07-19T03:59:59Z", "2024-11-07T01:34:16Z", null, 1, 0, "0900006485a20d0d"], ["FDA-2007-D-0369-0864", "FDA", "FDA-2007-D-0369", "PSG_214460 - Draft Guidance on Brincidofovir", "Other", "Guidance", "2023-05-19T04:00:00Z", 2023, 5, "2023-05-19T04:00:00Z", "2023-07-19T03:59:59Z", "2024-11-07T01:34:12Z", null, 1, 0, "0900006485a204e5"], ["FDA-2007-D-0369-0870", "FDA", "FDA-2007-D-0369", "PSG_215383 - Draft Guidance on Belzutifan)", "Other", "Guidance", "2023-05-19T04:00:00Z", 2023, 5, "2023-05-19T04:00:00Z", "2023-07-19T03:59:59Z", "2024-11-07T01:34:16Z", null, 1, 0, "0900006485a20d0f"], ["FDA-2007-D-0369-0873", "FDA", "FDA-2007-D-0369", "PSG_212194 -Draft Guidance on Givosiran Sodium", "Other", "Guidance", "2023-05-19T04:00:00Z", 2023, 5, "2023-05-19T04:00:00Z", "2023-07-19T03:59:59Z", "2024-11-07T01:34:09Z", null, 1, 0, "0900006485a22802"], ["FDA-2007-D-0369-0859", "FDA", "FDA-2007-D-0369", "PSG_213426 - Draft Guidance on Celecoxib; Tramadol Hydrochloride", "Other", "Guidance", "2023-05-19T04:00:00Z", 2023, 5, "2023-05-19T04:00:00Z", "2023-07-19T03:59:59Z", "2024-11-07T01:34:07Z", null, 1, 0, "0900006485a20571"]], "truncated": false, "filtered_table_rows_count": 199, "expanded_columns": [], "expandable_columns": [[{"column": "docket_id", "other_table": "dockets", "other_column": "id"}, "title"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "units": {}, "query": {"sql": "select id, agency_id, docket_id, title, document_type, subtype, posted_date, posted_year, posted_month, comment_start_date, comment_end_date, last_modified, fr_doc_num, open_for_comment, withdrawn, object_id from documents where \"docket_id\" = :p0 and \"posted_year\" = :p1 order by posted_date desc limit 101", "params": {"p0": "FDA-2007-D-0369", "p1": "2023"}}, "facet_results": {"agency_id": {"name": "agency_id", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?docket_id=FDA-2007-D-0369&posted_year=2023", "results": [{"value": "FDA", "label": "FDA", "count": 199, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2007-D-0369&posted_year=2023&agency_id=FDA", "selected": false}], "truncated": false}, "document_type": {"name": "document_type", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?docket_id=FDA-2007-D-0369&posted_year=2023", "results": [{"value": "Other", "label": "Other", "count": 156, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2007-D-0369&posted_year=2023&document_type=Other", "selected": false}, {"value": "Supporting & Related Material", "label": "Supporting & Related Material", "count": 36, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2007-D-0369&posted_year=2023&document_type=Supporting+%26+Related+Material", "selected": false}, {"value": "Notice", "label": "Notice", "count": 7, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2007-D-0369&posted_year=2023&document_type=Notice", "selected": false}], "truncated": false}, "posted_year": {"name": "posted_year", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?docket_id=FDA-2007-D-0369&posted_year=2023", "results": [{"value": 2023, "label": 2023, "count": 199, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2007-D-0369", "selected": true}], "truncated": false}}, "suggested_facets": [{"name": "subtype", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2007-D-0369&posted_year=2023&_facet=subtype"}, {"name": "posted_date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2007-D-0369&posted_year=2023&_facet=posted_date"}, {"name": "posted_month", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2007-D-0369&posted_year=2023&_facet=posted_month"}, {"name": "comment_start_date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2007-D-0369&posted_year=2023&_facet=comment_start_date"}, {"name": "comment_end_date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2007-D-0369&posted_year=2023&_facet=comment_end_date"}, {"name": "open_for_comment", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2007-D-0369&posted_year=2023&_facet=open_for_comment"}, {"name": "posted_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2007-D-0369&posted_year=2023&_facet_date=posted_date"}, {"name": "comment_start_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2007-D-0369&posted_year=2023&_facet_date=comment_start_date"}, {"name": "comment_end_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2007-D-0369&posted_year=2023&_facet_date=comment_end_date"}, {"name": "last_modified", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2007-D-0369&posted_year=2023&_facet_date=last_modified"}], "next": "2023-05-19T04~3A00~3A00Z,FDA-2007-D-0369-0859", "next_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2007-D-0369&posted_year=2023&_next=2023-05-19T04~3A00~3A00Z%2CFDA-2007-D-0369-0859&_sort_desc=posted_date", "private": false, "allow_execute_sql": true, "query_ms": 1043.2983040227555, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}